Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,674.06
    +1,613.80 (+3.29%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Global Vials Market Report 2021: Expanding Pharma Sector is Expected to Propel the Vials Market from $1,263.0 Million in 2020 to $3,047.0 Million by 2030

Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Vials Market Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) - Global Industry Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Due to the surging incidence of chronic and acute diseases, the pharmaceutical industry is booming. As many of the drugs are administered via injection, the expanding pharma sector is expected to propel the global vials market from $1,263.0 million in 2020 to $3,047.0 million by 2030, at an 8.6% CAGR between 2021 and 2030

Presently, the COVID-19 pandemic is wreaking havoc on the world, with more than 151 million cases and 3 million deaths recorded thus far. This has put the healthcare and pharma sectors under immense pressure to find a cure and a way to prevent the infection.

As a result, extensive research and development (R&D) has unearthed numerous drugs, many of which have already received the regulatory approval and are now being used worldwide. Since most of these drugs are injectables, the pandemic is impacting the vials market positively.

In the past, pharmaceutical and biotech companies dominated the vials market under the end user segment, and they will also witness the fastest growth in the usage of vials in the near future. As these firms manufacture drugs in bulk, they require vials in large numbers. The rising demand for more-effective drugs, owing to the increasing prevalence of chronic and acute diseases, is propelling the procurement of such products by biotech and pharma companies.

Europe is currently the most-productive vials market on account of the expansion of its pharmaceutical industry, presence of established industry players, rise in the awareness regarding the newly launched drugs, and high purchasing power of Europeans.

In the years to come, the demand for vials will likely witness the fastest surge in Asia-Pacific (APAC). Key vial and pharma companies in the region are increasing their production output to meet the increasing demand for COVID vaccines.

Major players in the global vials market include

  • Phoenix Glass LLC

  • Pacific Vial Manufacturing Inc.

  • Hanna Instruments

  • PIRAMIDA d.o.o.

  • O.Berk

  • Acme Vial and Glass Company LLC

  • SGD Pharma

  • Stevanato Group

  • SCHOTT AG

  • Gerresheimer AG

  • Corning Incorporated

  • Amposan S.A.

  • TricorBraun Inc.

  • Borosil Limited

  • Piramal Glass Limited

  • Nipro Corporation

  • PerkinElmer Inc.

  • Thermo Fisher Scientific Inc.

ADVERTISEMENT

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Glass Type
4.1.1.1 Borosilicate
4.1.1.2 Fused-silica
4.1.2 By End User
4.1.2.1 Pharmaceutical and biotech companies
4.1.2.1.1 By filling technology
4.1.2.1.1.1 Volumetric filling
4.1.2.1.1.2 Liquid-level filling
4.1.2.2 Biomedical research organizations
4.1.2.3 Medical
4.1.2.4 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing preference for glass vials
4.2.2 Drivers
4.2.2.1 Growing pharmaceutical industry
4.2.2.2 Rising production capacity of vial manufacturers
4.2.2.3 Increasing healthcare expenditure
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High cost of vials
4.2.3.2 High risk of breakage
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Increasing demand for vaccine packaging
4.3 Porter's Five Forces Analysis
4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast
5.1 By Glass Type
5.2 By End User
5.2.1 Market for Vials Used by Pharmaceutical and Biotech Companies, by Filling Technology
5.3 By Region

Chapter 6. Europe Market Size and Forecast

Chapter 7. North America Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Competitive Landscape
11.1 Recent Strategic Developments of Players
11.1.1 Expansions
11.1.2 Product Launches
11.1.3 Agreements and Partnerships
11.2 Market Share Analysis of Key Players
11.3 List of Market Players and Their Offerings

Chapter 12. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/u6gs5p

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900